Skip to content
NJ News HubNewsHub

Business

NJII president departs to launch Multiplex Bio

Source: NJBiz · Jul 28, 2026, 2:38 PM

AI-assisted briefing from the publisher’s public headline and excerpt — not original reporting. How we write briefings

NJII president departs to launch Multiplex Bio news image

Michael Johnson, president of the New Jersey Innovation Institute (NJII), is stepping down from his leadership role to launch Multiplex Bio, a new company focused on acquiring and developing Standard BioTools' Mass Cytometry business.

The move represents a significant shift for Johnson and underscores ongoing activity in New Jersey's life sciences and biotechnology sector, where established industry leaders continue to create new ventures and drive innovation in diagnostic and research technologies.

Key points

  • Michael Johnson departing NJII to lead new Multiplex Bio venture
  • Multiplex Bio will acquire Standard BioTools' Mass Cytometry business unit
  • Move reflects active biotech entrepreneurship in New Jersey's innovation ecosystem

FAQ

Who is Michael Johnson and what was his previous role?
Michael Johnson was president of the New Jersey Innovation Institute (NJII), a research and innovation organization in the state. He is now departing that position to launch Multiplex Bio.
What business will Multiplex Bio focus on?
Multiplex Bio will acquire and operate Standard BioTools' Mass Cytometry business, which provides diagnostic and research technology tools.
Why is this move significant for New Jersey?
It demonstrates that established biotech leaders in New Jersey continue to create new ventures and drive innovation in the life sciences sector, supporting the state's growing reputation in biotechnology and healthcare innovation.

Briefing prepared for NJ News Hub. Verify details on the original story. See our editorial policy.

Related